HDFC Pharma and Healthcare Fund

The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.

Growthvine rating: 4/5 — ranked #18 of 87 in category.

Fund basics

CategoryEquity: Sectoral
NAV₹22.65 (as of 2026-11-13)
AUM₹3,501 Cr
Expense ratio1.64%
RiskometerVery High
Fund managerNikhil Mathur
Exit load1% for redemption within 30 days

Performance & risk

Sharpe ratio1.33
Standard deviation16.11%
Max drawdown−15.07%
Alpha5.17
Beta0.97

Over 5 years, captured 102.9% of NIFTY Pharma's upside and 74.1% of its downside.

Market cap allocation

Large cap30.1%
Mid cap32.0%
Small cap37.9%

Concentration

Top 5 holdings33.8%
Top 10 holdings51.7%
Total holdings38

Top holdings

Top sectors

Calendar-year track record

YearReturnQuartileCategory rank
2026 (partial)31.4%Q1 (Top)#2 of 76
20251.2%Q2#29 of 69
202450.3%Q1 (Top)#1 of 58